Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
423.64
-3.59 (-0.84%)
Mar 25, 2025, 4:00 PM EST - Market closed
Elevance Health Employees
Elevance Health had 104,200 employees as of December 31, 2024. The number of employees decreased by 700 or -0.67% compared to the previous year.
Employees
104,200
Change (1Y)
-700
Growth (1Y)
-0.67%
Revenue / Employee
$1,696,833
Profits / Employee
$57,390
Market Cap
96.32B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 104,200 | -700 | -0.67% |
Dec 31, 2023 | 104,900 | 2,600 | 2.54% |
Dec 31, 2022 | 102,300 | 4,100 | 4.18% |
Dec 31, 2021 | 98,200 | 14,800 | 17.75% |
Dec 31, 2020 | 83,400 | 12,800 | 18.13% |
Dec 31, 2019 | 70,600 | 6,700 | 10.49% |
Dec 31, 2018 | 63,900 | 7,900 | 14.11% |
Dec 31, 2017 | 56,000 | 3,000 | 5.66% |
Dec 31, 2016 | 53,000 | 0 | - |
Dec 31, 2015 | 53,000 | 1,500 | 2.91% |
Dec 31, 2014 | 51,500 | 3,300 | 6.85% |
Dec 31, 2013 | 48,200 | 4,700 | 10.80% |
Dec 31, 2012 | 43,500 | 5,800 | 15.38% |
Dec 31, 2011 | 37,700 | 200 | 0.53% |
Dec 31, 2010 | 37,500 | -3,000 | -7.41% |
Dec 31, 2009 | 40,500 | -2,400 | -5.59% |
Dec 31, 2008 | 42,900 | 1,200 | 2.88% |
Dec 31, 2007 | 41,700 | -300 | -0.71% |
Dec 31, 2006 | 42,000 | 0 | - |
Dec 31, 2005 | 42,000 | 4,000 | 10.53% |
Dec 31, 2004 | 38,000 | 17,870 | 88.77% |
Dec 31, 2003 | 20,130 | 630 | 3.23% |
Dec 31, 2002 | 19,500 | 4,700 | 31.76% |
Dec 31, 2001 | 14,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ELV News
- 13 days ago - Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio - Seeking Alpha
- 27 days ago - Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now - Seeking Alpha
- 4 weeks ago - U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount - Seeking Alpha
- 4 weeks ago - Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1) - Seeking Alpha
- 5 weeks ago - Elevance Health Bolsters Employer Insurance Business - Forbes
- 6 weeks ago - Alphabet's Verily to sell Granular insurance business to Elevance Health - CNBC
- 7 weeks ago - Elevance Health Foundation Announces New Five-Year, $150 Million Commitment - Business Wire
- 7 weeks ago - My Top 15 High-Growth Dividend Stocks For February 2025 - Seeking Alpha